LEVEL 4 A16AB05

Δραστικές

Φάρμακα

  • DRUGBANK - Laronidase
  • indication:

    For the treatment of mucopolysaccharidosis

  • pharmacology:

  • mechanism:

    Laronidase catalyses the hydrolysis of terminal alpha-L-iduronic acid residues of dermatan sulfate and heparin sulfate.

  • toxicity:

  • absorprion:

  • halflife:

    1.5-3.6 hrs

  • roouteelimination:

  • volumedistribution:

  • clearance: